序号 | 股票代码 | 股票简称 | 纳入时间 | 申万1级 | 申万2级 | 申万3级 | 价格
|
市盈率
|
市盈率ttm
|
市净率
|
股息率
|
市值(亿元)
|
归母净利润同比增长(09-30)
|
归母净利润同比增长(06-30)
|
营业收入同比增长(09-30)
|
营业收入同比增长(06-30)
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 603456.SH | 九洲药业 | 2023-07-06 | — | — | 医疗研发外包 | 12.78 | 11.07 | 16.41 | 1.36 | 3.89% | 114.41 | -34.74% | -23.62% | -13.36% | -15.07% |
2 | 300363.SZ | 博腾股份 | 2014-02-12 | — | — | 医疗研发外包 | 14.11 | — | — | 1.48 | 3.43% | 76.97 | -145.68% | -141.43% | -30.02% | -42.19% |
3 | 301520.SZ | 万邦医药 | 2023-10-10 | — | — | 医疗研发外包 | 36.38 | 22.44 | 22.34 | 1.63 | 2.33% | 24.25 | 0.63% | 2.25% | 21.88% | 13.47% |
4 | 600721.SH | 百花医药 | 2008-01-25 | — | — | 医疗研发外包 | 6.63 | 61.4 | 61.4 | 3.36 | — | 25.47 | 35.39% | 74.32% | 9.38% | 17.40% |
5 | 300149.SZ | 睿智医药 | 2010-12-29 | — | — | 医疗研发外包 | 5.48 | — | — | 2.04 | — | 27.29 | -96.88% | -316.72% | -15.09% | -16.56% |
6 | 688238.SH | 和元生物 | 2023-09-25 | — | — | 医疗研发外包 | 4.98 | — | — | 1.86 | — | 32.32 | -166.90% | -153.01% | 34.22% | 35.00% |
7 | 301096.SZ | 百诚医药 | 2021-12-27 | — | — | 医疗研发外包 | 33.11 | 13.3 | 17.05 | 1.31 | 0.9% | 36.17 | -29.69% | 12.35% | 1.07% | 23.88% |
8 | 301201.SZ | 诚达药业 | 2022-01-27 | — | — | 医疗研发外包 | 21.99 | 37.39 | 48.47 | 1.53 | 0.89% | 34.02 | -33.98% | -14.23% | -6.34% | -1.55% |
9 | 301333.SZ | 诺思格 | 2022-08-09 | — | — | 医疗研发外包 | 46.15 | 31.79 | 31.79 | 2.43 | 0.43% | 44.57 | -32.93% | -31.94% | 7.10% | 4.71% |
10 | 301509.SZ | 金凯生科 | 2023-08-10 | — | — | 医疗研发外包 | 23.79 | 16.51 | 42.99 | 1.34 | 2.4% | 28.65 | -73.13% | -71.32% | -33.93% | -39.36% |
11 | 300347.SZ | 泰格医药 | 2012-08-24 | — | — | 医疗研发外包 | 45.95 | 98.1 | 98.1 | 1.92 | 1.23% | 397.44 | -56.72% | -64.50% | -10.32% | -9.50% |
12 | 688710.SH | 益诺思 | 2024-09-10 | — | — | 医疗研发外包 | 32.13 | 23.3 | 30.65 | 1.89 | — | 45.30 | -26.47% | -16.05% | 10.46% | 15.01% |
13 | 688202.SH | 美迪西 | 2023-09-25 | — | — | 医疗研发外包 | 27.45 | — | — | 1.72 | — | 36.97 | -211.99% | -142.27% | -32.24% | -40.23% |
14 | 688265.SH | 南模生物 | 2023-09-25 | — | — | 医疗研发外包 | 23.35 | — | 277.46 | 1.08 | — | 18.20 | -3.99% | -214.89% | -1.17% | -2.17% |
15 | 002821.SZ | 凯莱英 | 2016-11-25 | — | — | 医疗研发外包 | 64.07 | 24.35 | 24.35 | 1.46 | 2.78% | 231.03 | -67.86% | -70.40% | -35.14% | -41.63% |
16 | 688131.SH | 皓元医药 | 2023-09-25 | — | — | 医疗研发外包 | 34.82 | 36.44 | 36.44 | 2.66 | — | 73.46 | 21.31% | -25.77% | 17.65% | 19.82% |
17 | 300759.SZ | 康龙化成 | 2019-02-11 | — | — | 医疗研发外包 | 22.67 | 22.48 | 22.48 | 2.96 | 0.88% | 403.12 | 24.82% | 41.64% | 3.00% | -0.63% |
18 | 688046.SH | 药康生物 | 2023-09-25 | — | — | 医疗研发外包 | 11.18 | 28.84 | 39.59 | 2.14 | — | 45.84 | -16.57% | -1.59% | 12.13% | 15.05% |
19 | 300404.SZ | 博济医药 | 2015-05-04 | — | — | 医疗研发外包 | 8.66 | 136.29 | 74.39 | 3.35 | 0.11% | 33.17 | 87.98% | 71.04% | 55.01% | 46.92% |
20 | 300683.SZ | 海特生物 | 2024-07-31 | — | — | 医疗研发外包 | 20.63 | — | — | 1.12 | 0.63% | 27.00 | -50.32% | -104.58% | 2.87% | -0.64% |
21 | 688621.SH | 阳光诺和 | 2023-09-25 | — | — | 医疗研发外包 | 37.85 | 22.94 | 23.51 | 3.84 | — | 42.39 | 21.40% | 25.91% | 32.47% | 22.08% |
22 | 300725.SZ | 药石科技 | 2017-11-17 | — | — | 医疗研发外包 | 29.83 | 30.19 | 34.02 | 2.15 | 1.03% | 59.58 | -14.45% | -13.35% | -12.67% | -11.75% |
23 | 301257.SZ | 普蕊斯 | 2022-05-24 | — | — | 医疗研发外包 | 27.03 | 15.95 | 20.26 | 1.9 | 1.03% | 21.49 | -28.39% | -11.33% | 9.17% | 13.16% |
24 | 688073.SH | 毕得医药 | 2023-09-25 | — | — | 医疗研发外包 | 38.66 | 32.07 | 28.61 | 1.73 | — | 35.14 | -26.05% | -38.15% | 0.79% | 1.83% |
25 | 301230.SZ | 泓博医药 | 2022-11-08 | — | — | 医疗研发外包 | 25.5 | 94.62 | 513.72 | 3.45 | 1.37% | 35.59 | -66.81% | -51.42% | 6.59% | 11.83% |
26 | 603127.SH | 昭衍新药 | 2017-09-01 | — | — | 医疗研发外包 | 17.26 | 174.63 | 174.63 | 1.6 | 0.92% | 129.36 | -121.46% | -287.30% | -15.87% | -16.08% |
27 | 603259.SH | 药明康德 | 2018-05-15 | — | — | 医疗研发外包 | 51.61 | 15.77 | 15.77 | 2.54 | 1.94% | 1490.49 | -19.11% | -20.20% | -6.23% | -8.64% |
28 | 688222.SH | 成都先导 | 2023-09-25 | — | — | 医疗研发外包 | 13.2 | 129.89 | 103.83 | 3.8 | — | 52.89 | 64.71% | 75.19% | 21.38% | 25.10% |
免责声明:数据相关栏目所收集数据,均来自第三方个人或企业公开数据以及国家统计网站公开发布数据,数据由计算机技术自动收集更新再由作者校验,作者将尽力校验,但不能保证数据的完全准确。 阅读本栏目的用户必须明白,图表所示结果或标示仅供学习参考使用,均不构成交易依据。任何据此进行交易等行为,而引致的任何损害后果,本站概不负责。